Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Seo, Seung Hee ^a,c   Kim, Sung Eun ^a   Kang, Yoon Koo ^b   Ryoo, Baek Yeol ^b   Ryu, Min Hee ^b   Jeong, Jae Ho ^b   Kang, Shin Sook ^c   Yang, Mihi ^a   Lee, Jung Eun ^a   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Adverse events; Chemotherapy; Gastric cancer; Hypoalbuminemia; Malnutrition

Indexed keywords

ALBUMIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; BODY MASS; BODY WEIGHT; CONSTIPATION; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GASTRECTOMY; HAND FOOT SYNDROME; HEMATOLOGIC DISEASE; HUMAN; HYPERBILIRUBINEMIA; HYPERPIGMENTATION; HYPERTRANSAMINASEMIA; HYPOALBUMINEMIA; LEUKOPENIA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NAUSEA; NEUTROPENIA; NUTRITIONAL ASSESSMENT; NUTRITIONAL RISK INDEX; NUTRITIONAL STATUS; PATIENT GENERATED SUBJECTIVE GLOBAL ASSESSMENT; PREDICTION; RASH; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; VOMITING; ADVERSE EFFECTS; COMPLICATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROCEDURES; STATISTICAL MODEL; STOMACH NEOPLASMS;

ADULT; AGED; BODY MASS INDEX; CONSTIPATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEBRILE NEUTROPENIA; FEMALE; GASTRECTOMY; HUMANS; HYPOALBUMINEMIA; LOGISTIC MODELS; MALE; MALNUTRITION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; VOMITING;

EID: 84998773692     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2934-5     Document Type: Article

References (30)

1. von Meyenfeldt M. Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs. 2005;9 Suppl 2:S35-8.
2. La Torre M, Ziparo V, Nigri G, Cavallini M, Balducci G, Ramacciato G. Malnutrition and pancreatic surgery: prevalence and outcomes. J Surg Oncol. 2013;107(7):702-8.
3. Sanford DE, Sanford AM, Fields RC, Hawkins WG, Strasberg SM, Linehan DC. Severe nutritional risk predicts decreased long-term survival in geriatric patients undergoing pancreaticoduodenectomy for benign disease. J Am Coll Surg. 2014;219(6):1149-56.
4. Grant B, Byron J. Nutritional implications of chemoterapy. In: Elliot L, Molseed LL, McCallum PD, editors. The clinical guide to oncology nutrition. 2nd ed. Chicago: American Dietetic Association; 2006.
5. Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachex Sarcopenia Muscle. 2011;2(1):27-35.
6. Salas S, Deville JL, Giorgi R, Pignon T, Bagarry D, Barrau K, Zanaret M, Giovanni A, Bourgeois A, Favre R, et al. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiother Oncol. 2008;87(2):195-200.
7. Cessot A, Hebuterne X, Coriat R, Durand JP, Mir O, Mateus C, Cacheux W, Lemarie E, Michallet M, de Montreuil CB, et al. Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status. Support Care Cancer. 2011;19(7):869-70.
8. Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P. Validation of the Malnutrition Universal Screening Tool (MUST) in cancer. Br J Nutr. 2012;108(2):343-8.
9. McCallum PD, Polisena CG. The clinical guide to oncology nutrition. 1st ed. Chicago: American Dietetic Association; 2000.
10. Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer. 2010;18(3):373-81.
11. Marian M, Roberts S. Clinical nutrition for oncology patients. Sudbury: Jones & Bartlett Learning; 2010.
12. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810-20.
13. Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, et al. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer. Cancer Chemother Pharmacol. 2012;70(4):523-9.
14. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Kawasaki T, Satomi T. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function. Cancer Chemother Pharmacol. 2002;50(1):25-32.
15. Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotte P, Lerebours E, Michel P. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol. 2007;102(11):2557-63.
16. Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40(5):440-3.
17. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39(2):210-3.
18. Barber MD, Ross JA, Fearon KC. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer. 1999;35(2):106-10.
19. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia--pathophysiology and management. J Gastroenterol. 2013;48(5):574-94.
20. Numeroso F, Barilli AL, Delsignore R. Prevalence and significance of hypoalbuminemia in an internal medicine department. Eur J Intern Med. 2008;19(8):587-91.
21. Lis CG, Grutsch JF, Vashi PG, Lammersfeld CA. Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN J Parenter Enteral Nutr. 2003;27(1):10-5.
22. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, Calman KC. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985;1(8432):781-4.
23. Andersson C, Lonnroth C, Moldawer LL, Ternell M, Lundholm K. Increased degradation of albumin in cancer is not due to conformational or chemical modifications in the albumin molecule. J Surg Res. 1990;49(1):23-9.
24. Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, Serna-Thome MG, Flores-Estrada D, Diaz-Romero C, Rodriguez CM, Martinez L, Sanchez-Lara K. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010;10:50.
25. Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate JM, Louafi S, Mansourbakht T, Bonnetain F, Attar A, et al. Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology. 2011;81(5-6):395-402.
26. Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr. 2011;30(1):92-8.
27. Marx W, Kiss N, McCarthy AL, McKavanagh D, Isenring L. Chemotherapy-induced nausea and vomiting: a narrative review to inform dietetics practice. J Acad Nutr Diet. 2016;116(5):819-27.
28. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, et al. Diagnostic criteria for malnutrition - an ESPEN consensus statement. Clin Nutr. 2015;34(3):335-40.
29. White JV, Guenter P, Jensen G, Malone A, Schofield M. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr. 2012;36(3):275-83.
30. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315-21.